May 15, 2024
Research Toward a Cure Trials
A listing of clinical trials and observational studies related to the research effort to cure HIV infection, mainly derived from the clinicaltrials.gov online registry. Click the trial registry identifier numbers for a link to the full entry containing detailed information on the trial design, enrollment criteria, principal investigators and location(s).
May 13, 2024
Comments In Regard to NIAID’S Strategic Plan, May 2024
Letter / Comment
Treatment Action Group submitted comments in response to “Request for Information (RFI): Inviting Comments and Suggestions on NIAID’s Strategic Plan” highlighting the organization’s key priorities across the NIAID portfolio.
May 10, 2024
An Activist’s Guide to Rifapentine – TB Preventive Treatment: 3HP and 1 HP
Publication
Rifapentine, an off-patent drug that’s been around since the 1960s, is the cornerstone of the two most effective regimens to prevent tuberculosis (TB) in people at risk of the disease.
May 10, 2024
Director of Development
Treatment Action Group (TAG) seeks a dynamic, motivated, and skilled individual to become its Director of Development supporting the organization as it continues to grow.
May 9, 2024
Community Engagement on Microarray Patches
Webinar / Presentation
Join TAG for this May 31 webinar on the growing pipeline of microarray patches (MAPs) for various infectious diseases treatment and immunization.
May 8, 2024
Treatment Action Group Welcomes Two New Board Members
Statement / Press
Treatment Action Group (TAG) is pleased to announce that two new members have been elected to the Board of Directors, Ama Burnham and Dr. Stefan V. Goldberg.
May 7, 2024
Going Behind the Scenes at TAG
Follow along with one of our staff members on a typical day, and you’ll see the difference you make as a TAG donor and partner.
April 30, 2024
Empowering Health, Parts 1 and 2
Webinar / Presentation
On May 7 and 21, celebrate Pride season by joining TAG for an essential webinar that addresses the unique health concerns of the LGBTQ+ community, focusing on engaging LGBTQ patients.
April 18, 2024
TB Diagnostics Pipeline: New Tools & Opportunities to Improve Access to Testing
Webinar / Presentation
On May 15, 2024, TAG hosted this webinar on the TB Diagnostics Pipeline: New Tools & Opportunities to Improve Access to Testing.
April 10, 2024
Administrator
Treatment Action Group (TAG) seeks a highly motivated and organized Administrator to support the organization as it continues to grow. This position reports to TAG’s Director of Operations and Human Resources. This is a full-time, salaried position.
April 2, 2024
Treatment Action Group Is Organizational Sponsor of SYNChronicity 2024
Statement / Press
Treatment Action Group (TAG) is proud to be one of the organizational sponsors of SYNChronicity 2024 (SYNC 2024). This annual national conference for HIV, HCV, STIs, harm reduction, and LGBTQ health will be held in Arlington, Virginia, from May 29 – 31; more than 1500 attendees are expected to participate.
March 27, 2024
1/4/6×24 Mid-Campaign Report Launch Webinar
Webinar / Presentation
On March 27, 2024, the 1/4/6×24 Campaign and the Stop TB Partnership co-hosted a webinar to launch the Campaign’s new report: Getting Better Faster: Delivering on the Promise of New TB Treatments.
March 22, 2024
Mid-Campaign Report Highlights What’s Needed to Win Better, Shorter TB Treatments for All by End of 2024
Statement / Press
Universal implementation of the best available treatment for drug-susceptible tuberculosis (TB) stands to cut 6.3 million years off total treatment by 2030, a new analysis released today by the 1/4/6×24 Campaign coalition has found.
March 21, 2024
Getting Better Faster: Delivering on the Promise of New TB Treatments – A Report from the 1/4/6×24 Campaign
Publication
This report marks the midway point of the 1/4/6×24 Campaign, which calls for the universal implementation of best available TB regimens — as little as one month or once weekly for TB prevention, four months for drug-susceptible TB, and six months for drug-resistant TB — by the end of 2024.
March 18, 2024
Research in Action Awards 2024
Save the Date: Thursday, October 17, 2024, when our Research in Action Awards return this fall! Once again we’ll honor some of the most brilliant activists, scientists, and leaders in the fight to end HIV, tuberculosis (TB), and hepatitis C (HCV).
March 14, 2024
Navigating Change: Implementing Long-Lasting Injectable PrEP Treatment and the Evolution of Clinical Protocols
Webinar / Presentation
On March 26, 2024, TAG presented this webinar that discusses implementing long-lasting injectable PrEP treatments and the evolving landscape of HIV prevention.
March 14, 2024
2024 CROI Tuberculosis Research Round Up
Statement / Press
Treatment Action Group (TAG) welcomes the tuberculosis (TB) data presented at the 2024 Conference on Retroviruses and Opportunistic Infections (CROI). The highlights presented here cover the results of several phase II TB prevention and treatment trials.
March 12, 2024
TB Project Associate
Treatment Action Group (TAG) is seeking a highly motivated and organized TB Project Associate to support TAG’s advocacy portfolio on tuberculosis (TB). This position will report to the TB Project Co-Director and be based in New York City.
March 11, 2024
Policy Issue Briefs: BARDA and ARPA-H
Publication
These two policy briefs explore two as yet untapped sources for drug-resistant tuberculosis (DR-TB) research funding within the U.S. Department of Health and Human Services (HHS).
March 2, 2024
2024 Pre-CROI Community HIV Cure Research Workshop
Webinar / Presentation
The 2024 Pre-CROI Community HIV Cure Research Workshop took place on Saturday, March 2nd in Denver. This year’s workshop had a shorter format than in the past, but we plan to return to an all-day event in the future.
February 29, 2024
TPT Community Materials
Publication
These free educational materials are designed for community-based and civil society organizations to use to advocate for and teach people about TB preventive treatment (TPT).
February 28, 2024
Washington D.C. Community Consensus on the Earlier Inclusion of Pregnant Women and Persons in TB Research
Publication
In October 2023, sixteen members of the global TB community developed a consensus statement on the inclusion of pregnant and breastfeeding women and persons in TB treatment and vaccines research.
February 16, 2024
Effective Approaches to Engaging HIV Positive Homeless Populations
Webinar / Presentation
On February 27, 2024, TAG explored innovative strategies and successful interventions for addressing the unique challenges faced by people living with HIV who are experiencing homelessness.
February 14, 2024
TAG Announces New Board Leadership
Statement / Press
Treatment Action Group (TAG), the New-York-City-based activist research and policy think tank working to end the epidemics of HIV, TB, and hepatitis C, made leadership changes at its annual Board of Directors meeting on February 10, 2024.
February 7, 2024
TAG Statement on 2024 National Black HIV/AIDS Awareness Day (NBHAAD)
Statement / Press
In the collective effort to engage, educate, and empower advocates around the ongoing impacts on Black communities, and to raise awareness around persistent and new threats to equitably ending the HIV epidemic, this National Black HIV/AIDS Awareness Day beckons us to confront the shadows that linger within our communities, specifically among our Black and Brown queer community members.